发明名称 Tumor vascular marker-targeted vaccines
摘要 The present invention provides methods of immunizing a subject against a tumor, inhibiting tumor growth, inhibiting tumor recurrence, treating, suppressing the growth of, or decreasing the incidence of a tumor, overcoming tolerance to a tumor vasculature marker (TVM) in a subject comprising the step of administering a vaccine comprising a TVM or a nucleic acid encoding a TVM and related vaccines. The present invention also provides a method of targeting a tumor vasculature in a subject having a tumor comprising the step of contacting said subject with a labeled compound that binds a) a tumor vasculature marker (TVM) or b) a nucleic acid molecule encoding said TVM.
申请公布号 US9290556(B2) 申请公布日期 2016.03.22
申请号 US200913121638 申请日期 2009.09.29
申请人 THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 发明人 Coukos George;Facciabene Andrea
分类号 C07H21/04;A61K48/00;C07K14/47;A61K39/00;A61K51/10;C07K16/28 主分类号 C07H21/04
代理机构 Pearl Cohen Zedek Latzer Baratz LLP 代理人 Cohen Mark S.;Pearl Cohen Zedek Latzer Baratz LLP
主权项 1. A vaccine comprising a nucleic acid construct comprising a nucleic acid sequence encoding a tumor endothelial marker (TEM)-1 protein or immunogenic fragment thereof fused in frame to a nucleic acid sequence encoding the N-terminal domain of fragment C of tetanus toxoid (DOM).
地址 Philadelphia PA US